2024年10月1日 · Cardiovascular disease (CVD) associated with COVID-19 is likely a consequence of the dysregulation of the ACE/ACE2 system, first due to SARS-CoV-2 infection but exacerbated by comorbidities such as hypertension [9], [10], [11].

2020年7月20日 · COVID-19 can cause cardiovascular disorders, including myocardial injury, arrhythmias, acute coronary syndrome and venous thromboembolism. Several medications used for the treatment of COVID-19...

2021年4月15日 · We review SARS-CoV-2 clinical data implicating cardiovascular involvement, mechanisms underlying cardiovascular involvement, and implications for clinical management and future research directions.

This review summarizes findings up to date on the relationship between cardiovascular disease (CVD) and COVID-19. Recent findings: Preexisting CVD is a common condition among patients with COVID-19 and is associated with increased disease severity and mortality. Conversely, COVID-19 has various clinical manifestations on cardiovascular system ...

COVID-19 has become one of the leading causes of global mortality, with a disproportionate impact on persons with CVD. Studies of health facility admissions for CVD found significant decreases during the pandemic. Studies of hospital mortality for CVD were more variable.

2022年2月7日 · We show that, beyond the first 30 d after infection, individuals with COVID-19 are at increased risk of incident cardiovascular disease spanning several categories, including cerebrovascular...

2020年11月23日 · Given the presence of a large number of patients with CVD and the significance of the cardiovascular system, figuring out the interaction between SARS-CoV-2 infection and the cardiovascular system not only has evident implications for the diagnosis, treatment, and prognosis of COVID-19 but also is beneficial …

2020年3月21日 · COVID-19 is caused by severe acute respiratory syndrome coronavirus 2, which invades cells through the angiotensin-converting enzyme 2 receptor. Among patients with COVID-19, there is a high prevalence of cardiovascular disease, and >7% of patients experience myocardial injury from the infection (22% of critically ill patients).

2023年1月1日 · Irrespective of COVID-19's influence on CV health, the percentage of CVD cases in the United States (US), most notably stroke and HF, is forecasted to rise dramatically from 2025 to 2060, in tandem with the growing prevalence of CVD risk factors (e.g., diabetes, obesity, hypertension, dyslipidemia). 17 Arguably of greater concern is the ...

2023年2月11日 · Recent evidence suggests an interplay between COVID-19 and cardiovascular disease (CVD). COVID-19 may serve as a yet underappreciated CVD risk modifier, including risk factors such as diabetes mellitus or arterial hypertension.